-
Something wrong with this record ?
Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome
J. Svec, L. Schwarzová, B. Janošíková, J. Stekrová, V. Mandys, M. Kment, P. Vodička,
Language English Country United States
Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 2008
PubMed Central
from 2008
Europe PubMed Central
from 2008 to 2015
PubMed
25197397
Knihovny.cz E-resources
- MeSH
- Adaptor Proteins, Signal Transducing genetics MeSH
- Point Mutation MeSH
- Nuclear Proteins genetics MeSH
- Middle Aged MeSH
- Humans MeSH
- Neoplasms, Multiple Primary genetics pathology MeSH
- Sebaceous Gland Neoplasms genetics pathology MeSH
- Stomach Neoplasms genetics pathology MeSH
- Adenocarcinoma, Sebaceous genetics pathology MeSH
- Muir-Torre Syndrome genetics pathology MeSH
- Germ-Line Mutation MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Research Support, Non-U.S. Gov't MeSH
Muir-Torre syndrome (MTS), a rare variant of the hereditary non polyposis colorectal cancer syndrome, is an autosomal dominant genodermatosis characterised by coincidence of sebaceous gland neoplasms (sebaceous adenoma, epithelioma, or carcinoma) and at least one internal malignancy. The underlying cause of MTS is a germline mutation in DNA mismatch repair genes MSH2, MLH1 and MSH6. We report the case of a 52-year-old caucasian woman with the development of metachronous colon cancer at the age of 38 years, uterine cancer at the age of 43 years, and unique occurrence of synchronous gastric and sebaceous carcinomas related to germline point mutation c. 2194A>T in the last exon of MLH1 gene, resulting in truncated protein in C-terminal region p. Lys732X due to premature stop codon. This mutation, not previously reported in MTS, disrupts the function of MutL complexes presumably by preventing the interaction with PMS1/PMS2 and impairing the endonuclease active site. This case points out the importance of sebaceous neoplasia, especially sebaceous adenocarcinoma, as cutaneous markers of MTS for timely implementation of cancer screening programs.
2nd Department of Internal Medicine 3rd Faculty of Medicine Charles University Prague
Department of Pathology 3rd Faculty of Medicine Charles University Prague
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15023048
- 003
- CZ-PrNML
- 005
- 20150730094724.0
- 007
- ta
- 008
- 150709s2014 xxu f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)25197397
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Svec, Jiří $u 2nd Department of Internal Medicine, 3rd Faculty of Medicine, Charles University Prague ; Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic Prague.
- 245 10
- $a Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome / $c J. Svec, L. Schwarzová, B. Janošíková, J. Stekrová, V. Mandys, M. Kment, P. Vodička,
- 520 9_
- $a Muir-Torre syndrome (MTS), a rare variant of the hereditary non polyposis colorectal cancer syndrome, is an autosomal dominant genodermatosis characterised by coincidence of sebaceous gland neoplasms (sebaceous adenoma, epithelioma, or carcinoma) and at least one internal malignancy. The underlying cause of MTS is a germline mutation in DNA mismatch repair genes MSH2, MLH1 and MSH6. We report the case of a 52-year-old caucasian woman with the development of metachronous colon cancer at the age of 38 years, uterine cancer at the age of 43 years, and unique occurrence of synchronous gastric and sebaceous carcinomas related to germline point mutation c. 2194A>T in the last exon of MLH1 gene, resulting in truncated protein in C-terminal region p. Lys732X due to premature stop codon. This mutation, not previously reported in MTS, disrupts the function of MutL complexes presumably by preventing the interaction with PMS1/PMS2 and impairing the endonuclease active site. This case points out the importance of sebaceous neoplasia, especially sebaceous adenocarcinoma, as cutaneous markers of MTS for timely implementation of cancer screening programs.
- 650 _2
- $a adaptorové proteiny signální transdukční $x genetika $7 D048868
- 650 _2
- $a sebaceózní adenokarcinom $x genetika $x patologie $7 D018266
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a zárodečné mutace $7 D018095
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a Torrého-Muirův syndrom $x genetika $x patologie $7 D055653
- 650 _2
- $a mnohočetné primární nádory $x genetika $x patologie $7 D009378
- 650 _2
- $a jaderné proteiny $x genetika $7 D009687
- 650 _2
- $a bodová mutace $7 D017354
- 650 _2
- $a nádory mazových žláz $x genetika $x patologie $7 D012626
- 650 _2
- $a nádory žaludku $x genetika $x patologie $7 D013274
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Schwarzová, Lucie $u Institute of Biology and Medical Genetics, 1st Faculty of Medicine and General Teaching Hospital, Charles University Prague.
- 700 1_
- $a Janošíková, Bohumila $u Institute of Biology and Medical Genetics, 1st Faculty of Medicine and General Teaching Hospital, Charles University Prague.
- 700 1_
- $a Stekrová, Jitka $u Institute of Biology and Medical Genetics, 1st Faculty of Medicine and General Teaching Hospital, Charles University Prague.
- 700 1_
- $a Mandys, Václav $u Department of Pathology, 3rd Faculty of Medicine, Charles University Prague.
- 700 1_
- $a Kment, Milan $u 2nd Department of Internal Medicine, 3rd Faculty of Medicine, Charles University Prague.
- 700 1_
- $a Vodička, Pavel $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic Prague.
- 773 0_
- $w MED00165429 $t International journal of clinical and experimental pathology $x 1936-2625 $g Roč. 7, č. 8 (2014), s. 5196-202
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25197397 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20150730094812 $b ABA008
- 999 __
- $a ok $b bmc $g 1083387 $s 906041
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 7 $c 8 $d 5196-202 $i 1936-2625 $m International journal of clinical and experimental pathology $n Int. j. clin. exp. pathol. $x MED00165429
- LZP __
- $a Pubmed-20150709